Cytek Biosciences, Inc. Profile Avatar - Palmy Investing

Cytek Biosciences, Inc.

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytomete…

Medical - Devices
US, Fremont [HQ]
Financials

Analysts

Reported
Past Estimate Consensus
Future Estimate Consensus
EPS Revenue EBITDA EBIT SGA
FY EPS Revenue [mil.] Profit [mil.] EBITDA [mil.] EBIT [mil.] Expenses · SGA [mil.]
E E E E E E
2021 - 0.108 - 125 - 14 - 5 - 3 - 45
2022 0.0330 0.090 127 166 4 12 10 0.20 9 -3 45 59
2023 0.0192 -0.033 164 190 2 -4 9 0.23 -1 -3 67 68
2024 -0.0898 0.158 193 204 -12 23 -4 0.24 -27 -4 91 73
2025 - 0.210 - 227 - 33 - 0.27 - -4 - 81
2026 - 2.F5X/td> - 2.F5X/td> - 2.F5X/td> - 2.F51/td> - 2.F51 - 2.F51
2027 - 1.F6X/td> - 1.F6X/td> - 1.F6X/td> - 1.F61/td> - 1.F61 - 1.F61
2028 - 0.F7X/td> - 0.F7X/td> - 0.F7X/td> - 0.F71/td> - 0.F71 - 0.F71
End of CTKB's Analysis
CIK: 1831915 CUSIP: 23285D109 ISIN: US23285D1090 LEI: - UEI: -
Secondary Listings
CTKB has no secondary listings inside our databases.